Royal Pharmaceutical Society (RPS) - News updates

Certain pages on this news feed are only available to RPS members and hence requires members to log-in accordingly

Class 2 medicines recall: Ranitidine effervescent tablets 150mg and 300mg

Teva UK Limited trading as ratiopharm GmbH is recalling unexpired stock of Ranitidine effervescent tablets from pharmacies...

Have your say at our Annual Conference!

We're introducing a face-to-face forum for you to tell us how we’re doing at this year’s RPS Annual Conference. We’re calling it #RPSYourSay. This is your chance to get your voi

Chief Pharmacists welcome Wales palliative care proposals

The RPS in Wales has submitted proposals to the All Wales Chief Pharmacists Group around the implementation of recommendations made in our recent policy on pharmacy’s role in palliative and end

Class 4 medicines defect information: Xonvea 10 mg/10 mg gastro-resistant tablets

Alliance Pharmaceuticals Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that there are possible side effects not reported on the Patient Information Leaflet (PIL).

Class 4 Medicines Defect Information: Rifadin (rifampicin) 150mg Capsules (MDR 127-09/19)

Aventis Pharma Limited t/a Sanofi has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that a change to the Patient Information Leaflet, concerning possible side effects for Rif

Pharmacy alert: oral ranitidine formulations supply disruption

The Department of Health and Social Care (DHSC) has advised of a disruption to supply of all oral formulations of ranitidine until further notice.

RPS England Board Meeting – October update

RPS England Board Chair Claire Anderson comments on the highlights of the October meeting: “Our last Board meeting of the year marked the launch of our wellbeing survey on World Mental Health D

Drug Supply issues: Adrenaline Auto-Injectors, Nardil and Detrusitol XL

The Department of Health and Social Care (DHSC) has issued a supply issue update on Detrusitol XL, Adrenaline Auto-Injectors and Nardil...

RPS calls for equal access to wellbeing support for all pharmacists

On World Mental Health day (10 October) we are calling for all pharmacists to have equal access toservices to support their mental health and wellbeing. As a first step in our campaignwe've launch

Class 2 medicines recall: Zantac injection 50mg/2ml, Zantac syrup 150mg/10ml, Zantac tablets 150mg, Zantac tablets 300mg

GlaxoSmithKline, trading as Glaxo Welcome Ltd, is recalling all unexpired stock of Zantac (ranitidine hydrochloride) prescription only medicines (POM) from pharmacies.